Genetic variation in the CRP promoter: Association with systemic lupus erythematosus

Human Molecular Genetics

Volumn 17, Issue 8, 2008, Pages 1147-1155

  Edberg, Jeffrey C ^a   Wu, Jianming ^a   Langefeld, Carl D ^d   Brown, Elizabeth E ^b   Marion, Miranda C ^d   Mcgwin Jr , Gerald ^c   Petri, Michelle ^e   Ramsey Goldman, Rosalind ^f   Reveille, John D ^g   Frank, Summer G ^h   Kaufman, Kenneth M ^h,i,j   Harley, John B ^h,i,j   Alarcón, Graciela S ^a   Kimberly, Robert P ^a  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Kentucky   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

ⁱ US Department of Veteran Affairs   (United States)

^j UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PENTRAXIN;

5' UNTRANSLATED REGION; ADULT; AFRICAN AMERICAN; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; C-REACTIVE PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 41849103445     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn004     Document Type: Article

References (45)

1. Kyttaris, V., Krishnan, S. and Tsokos, G. (2006) Systems biology in systemic lupus erythematosus: Integrating genes, biology and Immune function. Autoimmunity, 39; 705-709.
2. Petri, M, (2006) Systemic lupus erythematosus: 2006, update. J. Clin. Rheumatol., 12, 37-40.
3. Fernández, M., Alarcón, G., Galvo-Alén, J., Andrade, R., McGwin, G.J., Vilá, L. and Reveille, J. (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum., 57, 576-584.
4. Alarcón-Viquelme, M. (2006) The genetics of systemic lupus erythematosus: Understanding how SNPs confer disease susceptibility. Springer Semin. Immunopathol., 28, 109-117.
5. Graham, R., Kyogoku, C, Sigurdsson, S., Vlasova, I., Davies, L., Baechler, E., Plenge, R., Koeuth, T., Ortmann, W., Hom, G. et al. (2001) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl Acad. Sci. USA, 104, 6758-6763.
6. Gregersen, P. and Behrens, T. (2006) Genetics of autoimmune diseases-disorders of immune homeostasis. Nat. Rev. Genet., 7 917-928.
7. Harley, J., Kelly, J. and Kaufman, K. (2006) Unraveling the genetics of systemic lupus erythematosus. Springer Semin. Immunopathol., 28 119-130.
8. Wu, H., Boackle, S., Hanvivadhanakul, P., Ulgiati, D., Grossman, J., Lee, Y., Shen, N., Abraham, L., Mercer, T., Park, E. et al. (2007) Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc. Natl Acad. Sci. USA, 104, 3961-3966.
9. Yang, Y., Chung, E., Wu, Y., Savelli, S., Nagaraja, H., Zhou, B., Hebert, H., Jones, K., Shu, Y., Kitzmiller, K. et al. (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): Low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am. J. Hum. Genet. 80, 1037-1054.
10. Alarcón, G., McGwin G.J., Petri, M., Ramsey-Goldman, R., Fessler, B., Vilá L., Edberg, J., Reveille, J. and Kimberly, R. (2006) Time to renal disease and end-stage renal disease in PROFILE: A multiethinic lupus cohort. PLoS Med., 3, e396.
11. Criswell, L., Pfeiffer, K., Lum, R., Gonzales, B., Novitzke, J., Kern, M., Moser, K., Begovich, A., Carlton, V., Li, W. et al. (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet., 76, 561-571.
12. Namjou, B., Kelly, J., Kilpatrick, J., Kaufman, K., Nath, S., Scofield, R. and Harley, J. (2005) Linkage at 5ql4.3-15 in multiplex systemic lupus crythematosus pedigrees stratified by autoimmune thyroid disease. Arthritis Rheum., 52, 3646-3650.
13. Graham, D., Graham, R., Manku, H., Wong, A., Whittaker, J., Gaffney, P., Moser, K., Rioux, J., Altshuler, D., Behrens, T. et al. (2007) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat. Genet, doi:10.1038/ ng.2007.47.
14. Mahoney, J. and Rosen, A. (2005) Apoptosis and autoimmunity, Curr. Opin. Immunol., 17, 583-588.
15. Mevorach, D. (2003) Systemic lupus erythematosus and apoptosis: A question of balance. Clin. Rev. Allergy Immunol., 25, 49-60.
16. Navratil, J., Liu, C. and Ahearn, J. (2006) Apoptosis and autoimmunity. Immunol. Res., 36, 3-12.
17. Ogden, C, and Elkon, K. (2006) Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr. Dir. Autoimmun., 9, 120-142.
18. Carroll, M. (2004) The complement system in regulation of adaptive immunity. Nat. Immunol., 5, 981-986.
19. Du Clos, T. (2003) C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum., 48, 1475-1477.
20. Marnell, L., Mold, C. and Du Clos, T. (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin. Immunol., 117, 104-111.
21. Pepys, M., Lanham, J. and De Beer, F. (1982) C-reactive protein in SLE. Clin. Rheum. Dis., 8, 91-103.
22. Rordorf, C., Schnebli, H., Baltz, M., Tennent, G. and Pepys, M. (1982) The acute-phase response in (NZB × NZW)F1 and MRL/1 mice. J. Exp. Medr, 156, 1269-1273.
23. Crawford, D., Yi, Q., Smith, J., Shephard, C., Wong, M., Witrak, L., Livingston, R., Rieder, M. and Nickerson, D. (2006) Allelic spectrum of the natural variation in CRP. Hum. Genet., 119, 496-504.
24. Crawford D., Sanders, C., Qin, X., Smith, J., Shephard, C., Wong, M., Witrak, L., Rieder, M. and Nickerson, D. (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation, 114, 2458-2465.
25. Carlson, C., Aldred, S., Lee, P., Tracy, R., Schwartz, S., Rieder, M., Liu, K., Williams, O., Iribarren, C., Lewis, E. et al. (2005) Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet., 77, 64-77.
26. Lange, L., Carlson, C., Hindorff, L., Lange, E., Walston, J., Durda, J., Cushman, M., Bis, J., Zeng, D., Lin, D. et al. (2006) Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA, 296, 2703 -2711.
27. Miller, D., Zee, R., Suk Danik, J., Kozlowski, P., Chasman, D., Lazarus, R., Cook, N., Ridker, P. and Kwiatkowski, D. (2005) Association of common CRR gene variants with CRP levels and cardiovascular events. Ann. Hum. Genet., 69, 623-638.
28. Pankow, J., Folsom, A., Cushman, M., Borecki, I., Hopkins, P., Eckfeldt, J. and Tracy, R. (2001) Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis, 154, 681-689.
29. Szalai, A., Wu, J., Lange, E., McCrory, M., Langefeld, C., Williams, A., Zakharkin, S., George, V., Allison, D., Cooper, G. et al. (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J. Mol. Med., 83, 440-447.
30. Hage, F. and Szalai, A. (2007). C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J. Am. Coll. Cardiol., 50, 1115-1122.
31. Russell A., Cunninghame Graham, D., Shepherd, C., Roberton, C., Whittaker, J., Meeks, J., Powell, R., Isenberg, D., Walport, M. and Vyse, T. (1004) Polymorphism at the C-reactive protein focus influences gene expression and predisposes to systemic lupus erythematosus. Hum. Mol. Genet., 13, 137-147.
32. Jönsen, A., Gunnarsson, I., Gullstrand B., Svenungsson, E., Bengtsson, A., Nived, O., Lundberg, I., Truedsson L. and Sturfelt, G. (2007) Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology (Oxford), 46, 1417-1421.
33. Edberg, J., Langefeld, C., Wu, J., Moser, K., Kaufman, K., Kelly, J., Bansal, V., Brown, W., Salmon, J., Rich, S. et al. (2002) Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum., 46, 2132-2140.
34. Alarcón, G., McGwin, G.J., Petri, M., Reveille, J., Ramsey-Goldman, R. and Kimberly, R. (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus, 11, 95-101.
35. SLEGEN Consortium (2008) A genome-wide association scan in women with systemic lupus, erythematosus (SLE) identifies ITGAM, PXK, KIAA1542 and rs10798269 and confirms HLA, STAT4, FCGR2A, IRF5, and PTPN22. Nat. Genet., in press.
36. Kimchi-Sarfaty, C., Oh, J., Kim, I., Sauna, Z., Calcagno, A., Ambudkar, S. and Gottesman, M. (2007) A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science, 315, 525-528.
37. Rodriguez, W., Mold, C., Kataranovski, M., Hutt, J., Marnell, L. and Du Clos, T. (2005) Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum., 52, 642-650.
38. Rodriguez, W., Mold, C., Marnell, L., Hutt, J., Silverman, G., Tran, D. and Du Clos, T. (2006) Prevention and reversal of nephritis MRL/ipr mice with a single injection of C-reactive protein. Arthritis Rheum., 54, 325-335.
39. Szalai, A., Nataf, S., Hu, X. and Baraum, S. (2002) Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol., 168, 5792-5797.
40. Szalai, A., Weaver, C., McCrory, M., van Ginkel, F., Reiman, R., Kearney, J., Marion, T. and Volanakis, J. (2003) Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum., 48, 1602-1611.
41. Berger, P., McConnell, J., Nunn, M., Komman, K., Sorrell, J., Stephenson, K. and Duff, G. (2002) C-reactive protein levels influenced by common IL-1 gene variations. Cytokine, 17, 171-174.
42. Vickers, M., Green, F., Terry, C., Mayosi, B., Julier, C., Lathrop, M., Ratcliffe, P., Watkins, H. and Keavney, B. (2002) Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc. Res., 53, 1029-1034.
43. Tan E., Cohen, A., Fries, J., Masi, A., McShane, D., Rothfield, N., Schaller, J., Talal, N. and Winchester R. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 25, 1271-1277.
44. Hochberg, M. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.
45. Wigginton, J., Cutler, D. and Abecasis, G. (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet., 76, 887-893.